RVMD ▼ -0.2% - Revolution Medicines, Inc.
$RVMD - Revolution Medicines Presents Updated Phase 1/2 Data for RASONQUE® (daraxonrasib) Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer at ENA 2026
19-NOV-2026 06:05 PM ET
Share this post
More filings for $RVMD
RVMD - Revolution Medicines, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026RVMD - Revolution Medicines, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026RVMD ▼ -3.0% - Revolution Medicines, Inc.Nov 16, 2026RVMD ▼ -2.4% - Revolution Medicines, Inc.Nov 16, 2026RVMD - Revolution Medicines, Inc. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026RVMD ▲ +13.2% - Revolution Medicines, Inc.Nov 4, 2026
View full $RVMD filing history →💬 Comments
Loading comments…
Leave a comment
